The endothelial cyclooxygenase pathway: Insights from mouse arteries

This publication has 120 references indexed in Scilit:

• Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system
  Proceedings of the National Academy of Sciences, 2012
• Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice
  Proceedings of the National Academy of Sciences, 2012
• Oxidative Stress-Dependent Cyclooxygenase-2-Derived Prostaglandin F _2α Impairs Endothelial Function in Renovascular Hypertensive Rats
  Antioxidants & Redox Signaling, 2012
• Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: Mechanisms of COX-2 inhibitor risk to heart disease
  Life Sciences, 2011
• Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis.
  Carcinogenesis, 2010
• Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events
  Proceedings of the National Academy of Sciences, 2010
• Endothelium-dependent contraction induced by acetylcholine in the chicken ductus arteriosus involves cyclooxygenase-1 activation and TP receptor stimulation
  Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2010
• Endothelium‐dependent contractions in SHR: a tale of prostanoid TP and IP receptors
  British Journal of Pharmacology, 2009
• Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A₂ and prostacyclin
  British Journal of Pharmacology, 2008
• The calcium ionophore A23187 induces endothelium‐dependent contractions in femoral arteries from rats with streptozotocin‐induced diabetes
  British Journal of Pharmacology, 2007